← Back to Search

Contact Lens

Control Lenses for Near-sightedness

N/A
Waitlist Available
Led By Pete Kollbaum
Research Sponsored by Coopervision, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4 weeks
Awards & highlights

Study Summary

This trial tests a new type of contact lens to see if it works well for everyday wearers.

Who is the study for?
This trial is for adults over 18 who are near-sighted with a prescription between -0.50 D to -6.00 D, have had an eye exam in the last year, can see at least 20/40 with their current glasses or contacts, and use comfilcon A lenses regularly. They must understand the consent form and follow the study schedule.Check my eligibility
What is being tested?
The study is testing reusable soft contact lenses made using a new process compared to those made by the current process. Participants will wear these test lenses in their daily lives to evaluate performance.See study design
What are the potential side effects?
Potential side effects may include discomfort while wearing the lenses, dry eyes, redness or irritation of the eye. These are common reactions that some people might experience when trying new contact lenses.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 4 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Visual Acuity

Trial Design

2Treatment groups
Experimental Treatment
Group I: Test LensesExperimental Treatment1 Intervention
Participants will wear Test Lenses for 4 weeks
Group II: Control LensesExperimental Treatment1 Intervention
Participants will wear Control Lenses for 4 weeks
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Control Lenses (comfilcon A with current process)
2023
N/A
~80
Test Lenses (comfilcon A with novel process)
2023
N/A
~80

Find a Location

Who is running the clinical trial?

Coopervision, Inc.Lead Sponsor
157 Previous Clinical Trials
13,832 Total Patients Enrolled
Pete KollbaumPrincipal InvestigatorIndiana University
1 Previous Clinical Trials
19 Total Patients Enrolled
~51 spots leftby Jun 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top